prazosin has been researched along with Appetite Disorders in 2 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Excerpt | Relevance | Reference |
---|---|---|
"Prazosin pretreatment at 2." | 1.32 | Noradrenergic modulation of ephedrine-induced hypophagia. ( Ho, DH; Miller, DK; Wellman, PJ, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Hicks, C | 1 |
Sabino, V | 1 |
Cottone, P | 1 |
Wellman, PJ | 1 |
Miller, DK | 1 |
Ho, DH | 1 |
2 other studies available for prazosin and Appetite Disorders
Article | Year |
---|---|
The Alpha-1 Adrenergic Receptor Antagonist Prazosin Reduces Binge-Like Eating in Rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Disease Models, Animal; Feeding and Eating Disorde | 2020 |
Noradrenergic modulation of ephedrine-induced hypophagia.
Topics: Adrenergic alpha-Antagonists; Animals; Central Nervous System Stimulants; Dopamine; Ephedrine; Feedi | 2003 |